American Journal of Neuroradiology 21:255-261 (2 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Efficacy of Trisacryl Gelatin Microspheres versus Polyvinyl Alcohol Particles in the Preoperative Embolization of Meningiomas
a From the Departments of Neuroradiology (M.B., M.W-M., E.H., L.S.), Neuropathology (R.K.), and Neurosurgery (R.B.), University of Würzburg, Germany.
BACKGROUND AND PURPOSE: Trisacryl gelatin microspheres are a new, commercially available nonabsorbable embolic agent. The purpose of this study was to evaluate their efficacy in the preoperative embolization of meningiomas as compared with polyvinyl alcohol (PVA) particles of various sizes.
METHODS: In 30 consecutive patients, trisacryl gelatin microspheres (150300 µm) were used for the preoperative superselective embolization of meningiomas (group 1). Thirty other consecutive patients had embolization with PVA particles of 45 to 150 µm (n = 15, group 2) and of 150 to 250 µm (n = 15, group 3). Extent of devascularization, intraoperative blood loss, blood transfusion, and hemostasis at the time of surgery were recorded for every patient. The inflammatory reaction, the extent of necrotic areas, and the most distal intravascular location of the embolic agent (arterial, arteriolar, precapillary, capillary) were recorded.
RESULTS: There was no significant difference in the extent of angiographic devascularization among the groups. Intraoperative blood loss differed significantly between groups 1 and 2 and groups 1 and 3, but not between groups 2 and 3. The trisacryl gelatin microspheres were located more distally in tumor vessels than were the PVA particles of either size. The extent of intratumoral necrosis was not significantly different between the two embolic agents. In all groups there was a mild inflammatory tissue reaction in the vicinity of the embolic agent.
CONCLUSION: Trisacryl gelatin microspheres may be effective in the preoperative embolization of meningiomas, producing significantly less blood loss at surgery than seen with PVA particles of either size, possibly because of the significantly more distal vascular penetration of the microspheres.
This article has been cited by other articles:
![]() |
N J Maxwell, N Saleem Amer, E Rogers, D Kiely, P Sweeney, and A P Brady Renal artery embolisation in the palliative treatment of renal carcinoma Br. J. Radiol., February 1, 2007; 80(950): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Kwak, H. J. Shim, S.-M. Han, and E. S. Park Chitin-based Embolic Materials in the Renal Artery of Rabbits: Pathologic Evaluation of an Absorbable Particulate Agent Radiology, July 1, 2005; 236(1): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Feng, B. A. Kienitz, C. Matsumoto, J. Bruce, M. Sisti, H. Duong, and J. Pile-Spellman Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1405 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bendszus, C. M. Monoranu, A. Schutz, I. Nolte, G. H. Vince, and L. Solymosi Neurologic Complications after Particle Embolization of Intracranial Meningiomas AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kubo, N. Kuwayama, Y. Hirashima, A. Takaku, T. Ogawa, and S. Endo Hydroxyapatite Ceramics As a Particulate Embolic Material: Report of the Physical Properties of the Hydroxyapatite Particles and the Animal Study AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1540 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Pelage, A. Laurent, M. Wassef, M. Bonneau, D. Germain, R. Rymer, P. Flaud, J. Martal, and J.-J. Merland Uterine Artery Embolization in Sheep: Comparison of Acute Effects with Polyvinyl Alcohol Particles and Calibrated Microspheres Radiology, August 1, 2002; 224(2): 436 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Worthington-Kirsch, G. A. Fueredi, S. C. Goodwin, L. Machan, G. A. Niedzwiecki, J. F. Reidy, J. B. Spies, W. J. Walker, J.-P. Pelage, O. Le Dref, et al. Polyvinyl Alcohol Particle Size for Uterine Artery Embolization Dr Pelage and colleagues respond: Radiology, February 1, 2001; 218(2): 605 - 606. [Full Text] |
||||


